Product Name: DRG2 antibody [N1C1]
Applications: WB-Ag
Predicted Target Size: 41 kDa (note)
Positive Controls: Target recombinant protein
Form Supplied: Liquid
Concentration: 0.93 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: developmentally regulated GTP binding protein 2
Background: The DRG2 gene encodes the developmentally regulated GTP-binding protein 2, a name derived from the fact that it shares significant similarity to known GTP-binding proteins. DRG2 was identified because it is expressed in normal fibroblasts but not in SV40-transformed fibroblasts. Read-through transcripts containing this gene and a downstream gene have been identified, but they are not thought to encode a fusion protein. This gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq]
Synonyms: DRG2 antibody, developmentally regulated GTP-binding protein 2 antibody, DRG-2 antibody, developmentally-regulated GTP-binding protein 2 antibody, developmentally regulated GTP binding protein 2 antibody
Cellular Localization:
CAS NO: 182004-65-5
Product: Docetaxel
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Recombinant protein encompassing a sequence within the center region of human DRG2. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity:
Conjugation: Unconjugated
Storage Buffer: 0.1M Tris, 0.1M Glycine, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/15610142?dopt=Abstract
